Obesity and Polycystic Ovary Syndrome: Implications for Pathogenesis and Novel Management Strategies

被引:172
|
作者
Barber, Thomas M. [1 ,2 ]
Hanson, Petra [1 ,2 ]
Weickert, Martin O. [1 ,2 ,3 ]
Franks, Stephen [4 ]
机构
[1] Univ Hosp Coventry & Warwickshire, Warwickshire Inst Study Diabet Endocrinol & Metab, Coventry, W Midlands, England
[2] Univ Warwick, Warwick Med Sch, Coventry, W Midlands, England
[3] Coventry Univ, Ctr Appl Biol & Exercise Sci, Coventry, W Midlands, England
[4] Imperial Coll London, Inst Reprod Med, London, England
关键词
Polycystic ovary syndrome; obesity; metabolism; OBSTRUCTIVE SLEEP-APNEA; EXERCISE TRAINING-PROGRAM; HORMONE-BINDING GLOBULIN; INSULIN-RESISTANCE; VISCERAL FAT; ANOVULATORY WOMEN; BODY-COMPOSITION; WEIGHT-LOSS; METABOLIC DYSFUNCTION; CARDIOMETABOLIC RISK;
D O I
10.1177/1179558119874042
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Polycystic ovary syndrome (PCOS) is a common female condition typified by reproductive. hyperandrogenic, and metabolic features. Polycystic ovary syndrome is a genetic condition, exacerbated by obesity. There is a close link between obesity and PCOS based on epidemiological data, and more recently corroborated through genetic studies. There are many mechanisms mediating the effects of weight-gain and obesity on the development of PCOS. The metabolic effects of insulin resistance and steroidogenic and reproductive effects of hyperinsulinaemia are important mechanisms. Adipokine production by subcutaneous and visceral fat appears to play a part in metabolic function, However, given the complexity of PCOS pathogenesis, it is important also to consider possible effects of PCOS on further weightgain. or at least on hampering attempts at weight-loss and maintenance through lifestyle changes. Possible mediators of these effects include changes in energy expenditure, mental ill health. or physical inactivity. In this brief review. we discuss the main mechanisms that underlie the association between obesity and PCOS, from divergent perspectives of weight-gain contributing to development of PCOS and vice versa. We also consider novel management options for women with obesity and PCOS.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Polycystic ovary syndrome: Etiology and pathogenesis
    Matalliotakis I.
    Kourtis A.
    Koukoura O.
    Panidis D.
    Archives of Gynecology and Obstetrics, 2006, 274 (4) : 187 - 197
  • [32] THE POLYCYSTIC OVARY SYNDROME - PATHOGENESIS AND TREATMENT
    BARNES, R
    ROSENFIELD, RL
    ANNALS OF INTERNAL MEDICINE, 1989, 110 (05) : 386 - 399
  • [33] Pathogenesis of hyperandrogenism in polycystic ovary syndrome
    Chang, Wendy Y.
    Azziz, Ricardo
    POLYCYSTIC OVARY SYNDROME: CURRENT CONTROVERSIES, FROM THE OVARY TO THE PANCREAS, 2008, : 281 - 294
  • [34] Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing
    Sadeghi, Hosna Mohammad
    Adeli, Ida
    Calina, Daniela
    Docea, Anca Oana
    Mousavi, Taraneh
    Daniali, Marzieh
    Nikfar, Shekoufeh
    Tsatsakis, Aristidis
    Abdollahi, Mohammad
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (02)
  • [35] Polycystic ovary syndrome and obesity in adolescents
    Reinehr, Thomas
    GYNAKOLOGISCHE ENDOKRINOLOGIE, 2018, 16 (03): : 179 - 190
  • [36] Polycystic ovary syndrome in adolescents with obesity
    Fu, Leyi
    Qu, Fan
    Pan, Jiexue
    Wang, Tian
    Wang, Fangfang
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2021, 67 (03): : 468 - 473
  • [37] Polycystic Ovary Syndrome, Obesity, and Pregnancy
    Joham, Anju E.
    Palomba, Stefano
    Hart, Roger
    SEMINARS IN REPRODUCTIVE MEDICINE, 2016, 34 (02) : 93 - 101
  • [38] Polycystic ovary syndrome: is obesity a symptom?
    Yildiz, Bulent O.
    WOMENS HEALTH, 2013, 9 (06) : 505 - 507
  • [39] Metformin in polycystic ovary syndrome - implications for management of gestational diabetes
    Holt, RIG
    DIABETES OBESITY & METABOLISM, 2005, 7 (06): : 766 - 767
  • [40] Exploring new frontiers in the management of polycystic ovary syndrome associated obesity
    Dokras, Anuja
    Norman, Robert
    FERTILITY AND STERILITY, 2025, 123 (01) : 5 - 7